snyder lab banner


Link to full Cairns BR bibliography via the NIH Pub Med Database

Selected Publications

Foxa2 and Cdx2 cooperate with Nkx2-1 to inhibit lung adenocarcinoma metastasis.
Li CM, Gocheva V, Oudin MJ, Bhutkar A, Wang SY, Date SR, Ng SR, Whittaker CA, Bronson RT, Snyder EL, Gertler FB, Jacks T. 
Genes Dev 2015; 29: 1850-62.

c-Jun promotes cell migration and drives expression of the motility factor ENPP2 in soft tissue sarcomas
Sioletic S, Czaplinksi J, Hu L, Fletcher JA, Fletcher CDM, Wagner AJ, Loda M, Demetri GD, Sicinska ET, Snyder EL.
Journal of Pathology 2014; 23:190-202.

Nkx2-1 represses a latent gastric differentiation program in lung adenocarcinoma.
Snyder EL, Watanabe H, Magendantz M, Hoersch S, Chen TA, Wang DG, Crowley D, Whittaker CA, Kimura S, Meyerson M, Jacks T.
Molecular Cell 2013; 50:185-199.

Integrated cistromic and expression analysis of amplified NKX2-1 in lung adenocarcinoma identifies LMO3 as a functional transcriptional target.
Watanabe H, Francis JM, Woo MS, Etemad B, Lin W, Fries DF, Peng S, Snyder EL, Tata PR, Izzo F, Schinzel AC, Cho J, Hammerman PS, Verhaak RG, Hahn WC, Rajagopal J, Jacks T, Meyerson M (2013).

Suppression of lung adenocarcinoma progression by Nkx2-1.
Winslow MM, Dayton TD, Verhaak RGW, Snyder EL, Kim-Kiselak CS, Feldser DM, Whitaker CA, Hubbard DD, Crowley D, Bronson RT, Chiang DY, Meyerson M and Jacks T.
Nature 2011; 473: 101-4.

Context-dependent transformation of adult pancreatic cells by oncogenic K-Ras.
Gidekel-Friedlander SY, Chu GC, Snyder EL, Girnius N, Dibelius G, Crowley D, Vasile E, DePinho RA, Jacks T.
Cancer Cell 2009; 16:379-89.

Identification of CD44v6+/CD24- breast carcinoma cells in primary human tumors by quantum dot-conjugated antibodies.
Snyder EL, Bailey D, Shipitsin M, Polyak K, Loda M.
Lab Invest 2009; 89: 857-866.

c-Jun amplification and overexpression are oncogenic in liposarcoma but not always sufficient to inhibit the adipocytic differentiation program.
Snyder EL, Sandstrom DJ, Law K, Fiore C, Sicinska E, Brito J, Bailey D, Fletcher JA, Loda M, Rodig SJ, Cin PD, Fletcher CDM
Journal of Pathology 2009; 218: 292-300

Enhanced targeting and killing of tumor cells expressing the CXC chemokine receptor 4 by transducible anti-cancer peptides.
Snyder EL*, Saenz CC*, Denicourt C, Meade BR, Cui X-S, Kaplan IM, Dowdy SF.
Cancer Research 2005; 65:10646-50.

Treatment of terminal peritoneal carcinomatosis by a transducible p53-activating peptide.
Snyder EL, Meade BR, Saenz CC, Dowdy SF.
PLoS Biology 2004; 2:186-193.

Transduction of full-length TAT fusion proteins into mammalian cells: TAT-p27 induces cell migration.
Nagahara H, Vocero-Akbani AM, Snyder EL, Ho A, Latham DG, Lissy NA, Becker-Hapak M, Ezhevsky SA, Dowdy SF.
Nature Medicine 1998; 4:1449-1452.